Zobrazeno 1 - 10
of 722
pro vyhledávání: '"polycythaemia vera"'
Autor:
Sergio Cabibbo, Giovanna Oriella Manenti, Agostino Antolino, Massimo Poidomani, Raffaele Elia, Giuseppe A. Palumbo, Francesco Di Raimondo
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss 4, Pp 393-396 (2024)
Introduction: Polycythaemia vera patients can present with arterial or venous vascular occlusive events such as thrombosis or cardiovascular disease; disease-related symptoms may significantly impact on the quality of life. The aim of this study was
Externí odkaz:
https://doaj.org/article/b99039a181ef4f259b406bfca89fb528
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 13, Iss 7, Pp 2772-2775 (2024)
In this case series, we report a 32-year-old male patient with myocardial infarction and 45-year-old female with portal vein thrombosis with splenic infarcts, which were the initial manifestations of polycythaemia vera. The awareness of myeloprolifer
Externí odkaz:
https://doaj.org/article/d86362d4a14742a2a1f814c1c1dd77af
Autor:
Lai Yee Orbell, Nouf Abutheraa, Andrew S Duncombe, Mary Frances McMullin, Ruben Mesa, Charlene M McShane, Glen James, Lesley A Anderson
Publikováno v:
eJHaem, Vol 4, Iss 4, Pp 1071-1080 (2023)
Abstract Alleviating symptom burden in patients with myeloproliferative neoplasms (MPNs) is imperative to achieving optimal management. Research remains to elucidate the relationship between the JAK2V617F (Janus kinase 2) mutation present in many MPN
Externí odkaz:
https://doaj.org/article/028c2022644a45cea8818fdbea71bab2
Autor:
Shanti Amé, Fiorenza Barraco, Jean‐Christophe Ianotto, Eric Jourdan, Jérôme Rey, Jean‐François Viallard, Mathieu Wémeau, Jean‐Jacques Kiladjian
Publikováno v:
eJHaem, Vol 4, Iss 3, Pp 779-791 (2023)
Abstract Primary myelofibrosis (PMF) and polycythaemia vera (PV) are rare BCR‐ABL1‐negative myeloproliferative neoplasms, associated with an increased risk of thrombosis, haemorrhagic complications and progression to fibrosis or leukaemia or fibr
Externí odkaz:
https://doaj.org/article/93d770a8d4704af4a6d4ff191daf4765
Autor:
Suditi Wasnik, Ashwini Rege Gundawar, Mangala Nagare, Varun Dake, Harsha Dangare, Smita Bhide
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 17, Iss 7, Pp 50-53 (2023)
Introduction: Thrombocytosis is characterised by an increased platelet count in the blood, defined as a count greater than 450,000 cells/μL. The incidental discovery of thrombocytosis often leads to unnecessary investigations and referrals, causi
Externí odkaz:
https://doaj.org/article/173cfe14cbd64ca7938fa6da212767b3
Autor:
Shumaila Asghar, Asad Mahmood Abbasi, Jawad Zafar, Helen Mary Robert, Ayesha Khursheed, Sadia Ali
Publikováno v:
Pakistan Armed Forces Medical Journal, Vol 74, Iss 1 (2024)
Objective: To assess the frequency of erythrocytosis and compare the clinical features and haematological parameters in patients presenting with primary and secondary erythrocytosis in the Pakistani population. Study Design: Cross-sectional study.
Externí odkaz:
https://doaj.org/article/435edc6c341a4432a92baeccb2f38824
Autor:
Umi Kalsom Mohamad Yusof, Syamsiah Mashohor, Marsyita Hanafi, Sabariah Md Noor, Norsafina Zainal
Publikováno v:
Data in Brief, Vol 50, Iss , Pp 109484- (2023)
Tumorous cancer has been a widely known and well-studied medical phenomenon; however, rare diseases like Myeloproliferative Neoplasm (MPN) have received less attention, leading to delayed diagnosis. Despite the availability of advanced technology in
Externí odkaz:
https://doaj.org/article/8c4c9bb789ed4226ac5aa28b2256d905
Publikováno v:
eJHaem, Vol 3, Iss 4, Pp 1305-1309 (2022)
Abstract Hydroxycarbamide (HC) is used as a cytoreductive treatment in myeloproliferative neoplasms (MPN). Observational studies have raised the possibility that HC contributes to the development of secondary malignancies, including skin tumours in M
Externí odkaz:
https://doaj.org/article/e227082c1857411d91eeb12e2888d670
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.